VANGUARD GROUP INC 13D and 13G filings for Cardiovascular Systems, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Cardiovascular Systems, Inc. CSII | VANGUARD GROUP INC | 2,845,055 6.790% | 144,677 (+5.36%) | Filing |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Cardiovascular Systems, Inc. CSII | VANGUARD GROUP INC | 2,700,378 6.660% | 183,697 (+7.30%) | Filing |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Cardiovascular Systems, Inc. CSII | VANGUARD GROUP INC | 2,516,681 6.270% | 283,779 (+12.71%) | Filing |